Steven Marotta
Stock Analyst at CL King
(0.56)
# 3,917
Out of 4,865 analysts
15
Total ratings
37.5%
Success rate
-15.08%
Average return
Main Sectors:
Stocks Rated by Steven Marotta
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GIII G-III Apparel Group | Downgrades: Neutral | n/a | $21.46 | - | 1 | Dec 1, 2022 | |
| SHOO Steven Madden | Upgrades: Buy | n/a | $24.23 | - | 1 | Sep 28, 2022 | |
| CTKB Cytek Biosciences | Initiates: Overweight | $28 | $3.30 | +749.77% | 1 | Aug 17, 2021 | |
| AVTR Avantor | Upgrades: Overweight | $32 → $41 | $13.44 | +205.06% | 3 | Aug 2, 2021 | |
| CAL Caleres | Upgrades: Buy | $29 | $13.53 | +114.34% | 2 | Jun 1, 2021 | |
| CROX Crocs | Downgrades: Neutral | n/a | $102.24 | - | 3 | Jul 17, 2020 | |
| GCO Genesco | Upgrades: Buy | n/a | $21.87 | - | 4 | Jan 21, 2020 |
G-III Apparel Group
Dec 1, 2022
Downgrades: Neutral
Price Target: n/a
Current: $21.46
Upside: -
Steven Madden
Sep 28, 2022
Upgrades: Buy
Price Target: n/a
Current: $24.23
Upside: -
Cytek Biosciences
Aug 17, 2021
Initiates: Overweight
Price Target: $28
Current: $3.30
Upside: +749.77%
Avantor
Aug 2, 2021
Upgrades: Overweight
Price Target: $32 → $41
Current: $13.44
Upside: +205.06%
Caleres
Jun 1, 2021
Upgrades: Buy
Price Target: $29
Current: $13.53
Upside: +114.34%
Crocs
Jul 17, 2020
Downgrades: Neutral
Price Target: n/a
Current: $102.24
Upside: -
Genesco
Jan 21, 2020
Upgrades: Buy
Price Target: n/a
Current: $21.87
Upside: -